Tuesday, September 29, 2026

14:30 - 15:15

SPEAKERS' CORNER 1: DOROTEA BARNÉS

---

Overview

Sponsor: FARMAINDUSTRIA

---

Details

The Biotech Act will establish the first comprehensive framework to promote biotechnology as a strategic sector for the European Union’s competitiveness, public health, sustainability, and technological autonomy. The law aims to position Europe in the global competition with the United States and China in this strategically important field. About fostering biotechnology startup companies in the health sector, the Biotech Act outlines the structural conditions and mechanisms needed to accelerate innovation and improve the translation of research into market applications, so that such initiatives may be recognized by the Commission as “high impact health biotechnology strategic projects”. The Biotech Act advocates for achieving critical mass through clusters - not hundreds of small biotechnology hubs scattered everywhere - but rather half a dozen large “super-clusters” capable of attracting substantial investment and offering strong, competitive capacities in innovation, manufacturing, and infrastructure.

---

Details